Most people believe a clinical trial fails because of something that happens during the study. A protocol deviation. A regulatory delay. A recruitment slowdown. But the truth is far simpler. Most trials fail long before the first participant ever steps into a site. One of the most critical choices a sponsor has to make is […]
The FDA approved 50 new drugs in 2024, compared to roughly 35 in 2023, signaling steady growth in drug approvals. This has led to an increase in demand for medical writing services. High-quality medical writing is one of the most critical foundations of clinical research. Every protocol, clinical study report, regulatory submission and safety document must […]
Early-phase clinical trials, particularly Phase I and early Phase II, are often seen as exploratory stepping stones. Yet, what happens at these stages can determine the fate of an entire drug development program. At the heart of these early decisions lies biostatistics: the scientific foundation that transforms raw observations into meaningful insight. Unfortunately, many sponsors underestimate its importance. Poor biostatistical […]
Sponsors face mounting pressure to deliver high-quality trials on time and within budget. That’s why having a reliable partner for clinical monitoring is critical. Whether you’re considering traditional clinical trial monitoring or exploring hybrid models, the right monitoring partner can turn oversight from a cost centre into a value driver. At Innovate Research, we’ve seen how an intelligent, data-driven approach to monitoring can transform oversight into measurable operational and […]
